Search research articles
Contact Us
Filters
Showing results (41-50 of 189) with videos related to
Page
of 19
Sort By:
Antimicrobial Agents and Chemotherapy
|
August 1, 1984
Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus
A S Bayer, J O Morrison
Seminars in Arthritis and Rheumatism
|
November 1, 1978
Fungal arthritis. I. Candida arthritis: diagnostic and prognostic implications and therapeutic considerations
A S Bayer, L B Guze
Chest
|
July 1, 1990
Valve site-specific pathogenetic differences between right-sided and left-sided bacterial endocarditis
A S Bayer, D C Norman
Antimicrobial Agents and Chemotherapy
|
December 1, 1991
Comparison of fluconazole and amphotericin B for prevention and treatment of experimental Candida endocarditis
M D Witt, A S Bayer
Springer Seminars in Immunopathology
|
January 1, 1989
Immune complexes in infective endocarditis
A S Bayer, A N Theofilopoulos
Infectious Disease Clinics of North America
|
March 1, 1988
Life-threatening deep fascial space infections of the head and neck
I K Blomquist, A S Bayer
The Journal of Antimicrobial Chemotherapy
|
April 1, 1987
Significance of in-vitro penicillin tolerance in experimental enterococcal endocarditis
K S Kim, A S Bayer
Antimicrobial Agents and Chemotherapy
|
July 14, 1998
Efficacy of trovafloxacin, a new quinolone antibiotic, in experimental staphylococcal endocarditis due to oxacillin-resistant strains
A S Bayer, C Li, M Ing
The Journal of Infectious Diseases
|
October 1, 1985
Efficacy of ciprofloxacin in experimental arthritis caused by Escherichia coli--in vitro-in vivo correlations
A S Bayer, D Norman, D Anderson
Archives of Internal Medicine
|
January 13, 1997
Antibiotic prophylaxis for bacterial endocarditis: an evolving story with new paradigms
G Zuccaro, W Wilson, A S Bayer
Page
of 19
Search research articles
Search
Showing results (41-50 of 189) with videos related to
Sort By:
Page
of 19
Antimicrobial Agents and Chemotherapy
|
August 1, 1984
Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus
A S Bayer, J O Morrison
Seminars in Arthritis and Rheumatism
|
November 1, 1978
Fungal arthritis. I. Candida arthritis: diagnostic and prognostic implications and therapeutic considerations
A S Bayer, L B Guze
Chest
|
July 1, 1990
Valve site-specific pathogenetic differences between right-sided and left-sided bacterial endocarditis
A S Bayer, D C Norman
Antimicrobial Agents and Chemotherapy
|
December 1, 1991
Comparison of fluconazole and amphotericin B for prevention and treatment of experimental Candida endocarditis
M D Witt, A S Bayer
Springer Seminars in Immunopathology
|
January 1, 1989
Immune complexes in infective endocarditis
A S Bayer, A N Theofilopoulos
Infectious Disease Clinics of North America
|
March 1, 1988
Life-threatening deep fascial space infections of the head and neck
I K Blomquist, A S Bayer
The Journal of Antimicrobial Chemotherapy
|
April 1, 1987
Significance of in-vitro penicillin tolerance in experimental enterococcal endocarditis
K S Kim, A S Bayer
Antimicrobial Agents and Chemotherapy
|
July 14, 1998
Efficacy of trovafloxacin, a new quinolone antibiotic, in experimental staphylococcal endocarditis due to oxacillin-resistant strains
A S Bayer, C Li, M Ing
The Journal of Infectious Diseases
|
October 1, 1985
Efficacy of ciprofloxacin in experimental arthritis caused by Escherichia coli--in vitro-in vivo correlations
A S Bayer, D Norman, D Anderson
Archives of Internal Medicine
|
January 13, 1997
Antibiotic prophylaxis for bacterial endocarditis: an evolving story with new paradigms
G Zuccaro, W Wilson, A S Bayer
Page
of 19